Page last updated: 2024-10-31

midazolam and Respiratory Syncytial Virus Infections

midazolam has been researched along with Respiratory Syncytial Virus Infections in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouchut, JC1
Mallet, E1

Other Studies

1 other study available for midazolam and Respiratory Syncytial Virus Infections

ArticleYear
Weaning directly from high frequency oscillatory ventilation: the 'open lung' strategy expanded to weaning?
    Paediatric anaesthesia, 2004, Volume: 14, Issue:12

    Topics: Anesthetics, Intravenous; Blood Gas Analysis; Bronchiolitis; Bronchodilator Agents; Female; Fentanyl

2004